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1. Introduction
   Stemona tuberosa (S. tuberosa) Lour (Stemonaceae), known 
as Bach Bo in Vietnam, is a hairless, perennial, herbaceous 
twiner which can grow up to 4-10 m long. Its roots form a 
fascicle of many thick, fleshy shoots. The root of S. tuberosa 
has been used in Vietnamese traditional medicine for 
its antitussive and anti-ectoparasitic activities moisten 
the lungs and stop cough, as well as kill parasites[1]. The 
chemical constituents of the plant are alkaloids, stilbenoides 
and tocopherols[2,3]. Recently, S. tuberosa extracts have been 
attracting new interest for their multi-biological functions 
including anti-tuberculotic, antifungal, demulcent, and 
anti-cancer activities[1,2]. However, the anti-inflammatory 
activity of this plant required further investigation. In this 
study, we aimed to examine the anti-inflammatory activity 
and potential mechanisms of action in lipopolysaccharide 
(LPS)-activated macrophage cells for methyl ferulate (MF) 
isolated from roots of S. tuberosa.
2. Materials and methods
2.1. Plant material 
   The roots of S. tuberosa and eleven other traditional 
medicinal plants for screening test were collected in 
Quang Binh, Thanh Hoa, Phu Tho, Hoa Binh provinces 
and identified by the Institute of Ecology and Biological 
Resources, Vietnam Academy of Science and Technology, 
Hanoi. 
2.2. Chemicals
   LPS was purchased from Sigma-Aldrich (St. Louis, MO). 
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ELISA kits for IL-6, IL-10, TNFα, IFNγ were purchased from 
BD Pharmingen (Franklin Lakes, NJ). Antibodies p38 and 
phospho-(Thr180/Tyr182)-p38, c-Jun NH2-terminal kinase 
(JNK) and p-JNK were purchased from Cell Signalling 
Technology (Beverly, MA). The anti-cyclooxygenase-2 
(COX-2) antibody was purchased from Abfrontier (Korea). The 
NO detection kit was purchased from iNtRON Biotechnology 
(Korea). All chemicals used were of analytical grade. 
2.3. Extraction and isolation
   The air-dried and powdered roots of S. tuberosa (2.0 
kg) were extracted five times with 75% methanol (5伊10 L) 
in ultrasound extracting system (Elma, Japan) at room 
temperature and filtered. The combined extract was 
concentrated to dryness by evaporating in vacuo to give a 
residue (18 g), which was used for antiflammatory screening 
assays. The residue was chromatographed on silica gel 
(200-300 mesh) column chromatography, eluting with an 
ether:acetone gradient (9:1) to give 10 fractions E 1-10. The 
further separation of fraction E4 (0.82 g) by silica gel column 
chromatography eluted with a hexane:ethyl acetate gradient 
(2:1), yielded ten fractions (H1-10). Compound 1 (85 mg) was 
obtained from fraction H5 by preparative high performance 
liquid chromatography (HPLC) (hexane-EtOAc, 2/1; flow rate 
1 mL/min). 
2.4. Cell culture
   Primary bone marrow derived-macrophages (BMDMs) were 
isolated from the bone marrow of mice, which were reviewed 
and approved by the animal care unit of National Institute 
of Hygiene and Epidemiology, Vietnam. The cells were 
differentiated for 5-7 d in macrophage colony-stimulating 
factor (M-CSF)-containing media. The medium contains 
Dulbecco’s modified Eagle’s medium (DMEM, Gibco-BRL, 
Gaithersburg, MD) with 10% L929 cell-conditioned medium 
(as a source of M-CSF), 10% heat-inactivated fetal bovine 
serum (FBS) (Gibco-BRL), 1 mmol/L sodium pyruvate, 50 
IU/mL penicillin, 50 µg/mL streptomycin and 5伊10
5 mol/
L β-mercaptoethanol, sodium pyruvate, non-essential 
amino acids, penicillin G (100 IU/mL), and streptomycin 
(100 µg/mL). Mouse macrophage cell line, RAW264.7 
(American Type Culture Collection; ATCC) was maintained 
in complete medium (DMEM with 10% FBS), sodium pyruvate, 
non-essential amino acids, penicillin G (100 IU/mL), and 
streptomycin (100 µg/mL). 
2.5. Cell viability assay
   Cell viability assessment was performed using a Cell 
Counting Kit-8 (CCK-8, Dojindo Laboratories, Kumamoto, 
Japan) as per the manufacturer’s instructions. Briefly, 10 
µL of CCK-8 solution was added and incubated with treated 
cells for 60 min in Corning Costar 48 well plate and then 
absorbance was measured at 450 nm. Values from each 
treatment were calculated as a percent relative to the 
untreated control (100% survival).
2.6. ELISA
      BMDMs were treated in Corning Costar 48 well plate 
as indicated in the Figures 3 and 4. The cell-culture 
supernatants were analyzed for levels of cytokines TNFα, IL6, 
IL10, and IFN-γ secreted by cell culture were measured by 
ELISA reagents (BD Pharmingen). 
2.7. Western blotting
   The treated BMDMs were processed for analysis by Western 
blotting[4]. Briefly, BMDMs were treated with the test agent for 
60 min in Corning Costar 48 well plate before stimulation with 
LPS (1 µg/mL). The total cell lysates obtained by using lysis 
buffer NP 40% (Life Technologies) were then separated by 10% 
sodium dodecyl sulfate polyacrylamide gel electrophoresis 
and transferred overnight to nitrocellulose membranes, 
(AmershamTM HybondTM-ECL) and the nonspecific binding 
of antibodies was blocked with 3% nonfat dried milk in 
phosphate-buffered saline. Membranes were probed with 
p38, p-p38, JNK, and p-JNK antibodies (1:1 000 dilution in 
Tris-buffered saline, pH 7.4) for 2 h at room temperature. 
After three washes with phosphate-buffered saline, blots 
were developed by a chemiluminescence assay (ECL; 
Amersham-Pharmacia).
2.8. Measurement of NO content
   Raw 246.7 cells at density of 106 were seeded in Corning 
Costar 48 well plate for 16 h before treatment. The cells were 
treated with the test agent for 60 min and activated with 1 
µg/mL of LPS. The culture supernatants were obtained by 
centrifuge and concentrations of NO were assessed by Griess 
reaction using a NO detection kit (iNtRON Biotechnology, 
Korea).
2.9. Determination of COX-2 expression
   RAW 246.7 cells were treated with test agent in Corning 
Costar 48 well plate for 60 min before stimulation with 
LPS (1 µg/mL). The total cell lysates were then analyzed 
with Western blot using anti–COX-2 antibody (Santa Cruz 
Biotechnology Inc., Santa Cruz, CA). The antibodies were 
diluted at ratio of 1:1 000. The membranes were developed by 
a chemiluminescence assay (ECL; Amersham-Pharmacia).
2.10. Statistical analyses
   For statistical analysis, data obtained from independent 
experiments are presented as mean依SD and were analyzed 
by the Student’s t-test with ANOVA for multiple comparisons. 
Differences were considered significant at P<0.05.
3. Results 
3.1. Isolation of potential anti-inflammatory agent(s) from 
S. tuberosa extract
   Macrophages and lymphocytes produce powerful pro-
inflammatory mediators, including IL6, IL1, IL8, and 
TNFα, one of the most important mediators that regulates 
biochemical changes and symptomatic pathophysiological 
responses in the human body. In later stages of sepsis, 
anti-inflammatory mediators are produced (e.g. IL10), 
leading to an abatement in the production of many of the 
pro-inflammatory mediators[5]. Macrophages activated 
by bacterial LPS induce antibody production and local 
inflammation, which includes the release of pro-
Nguyen Thi Mai Phuong et al./Asian Pac J Trop Med 2014; 7(Suppl 1): S327-S331 S329
inflammatory cytokines, chemokines, and inflammatory 
mediators[5]. Therefore, macrophage cell lines are routinely 
used to evaluate the anti-inflammatory activities of crude 
extracts. 
   In this study, assaying LPS-activated macrophages in vitro, 
we screened for a potential anti-inflammatory extract from 
12 traditional medicinal plants of Vietnam by measurement 
of IL6 and TNFα production when LPS-induced macrophage 
cells were treated with these plant extracts. We found that 
a methanolic S. tuberose extract strongly inhibited pro-
inflammatory IL6 and TNFα release while it did not affect the 
release of the anti-inflammatory cytokine IL10, suggesting 
that the extract possesses potential anti-inflammatory 
properties (data not shown). Based on this result, S. tuberosa 
was selected for isolation of the desired compound. The 
isolation process was based on the bioassay-guided 
chromatographic separations. Compound 1 (85 mg) in the 
form of a yellow-brown oil was received by a preparative 
chromatography system after two repeated silica gel column 
chromatography steps showed a purity of up to 99% by 
HPLC. The obtained nuclear magnetic resonance (NMR) 
spectroscopic data indicated that compound 1 is MF with a 
molecular fomular of C11H13O4 (Figure 1), which displays the 
following spectral data: UV (MeOH)_max nm: 236, 322; IR 
(KBr) _max cm-1: 3424, 2903, 2649, 2549, 1744, 1670; EIMS m/z: 
208 [M]+, 177, 145, 137, 131, 89, 77, 51; 1H and 13C NMR (Table 1).
   Ferulic acid and some derivatives, especially ethyl 
ferulate, have been reported to be effective antioxidant, 
anti-microbial, anti-inflammatory, hepatoprotective, 
neuroprotective, anticarcinogenic, anti-diabetic, anti-
cholesterolemic, UV-protective and radioprotective 
compounds[6,7]. However, anti-inflammatory activity of MF 
derivative has not been well documented.
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Figure 1. Chemical structure of methyl ferulate isolated from S. tuberosa.
Table 1
The spectroscopic data of MF (CDCl3) about compound of 
1
H NMR and 13C NMR. 
Position Compound 1
1
H NMR (J, Hz) 13C NMR
1  167.7 
2 6.28 d, J=16.0 115.2
3 7.62 d, J=16.0 145.0
4 126.9
5 7.03 brd s 109.4
6 148.0
7 146.8 
8 6.92 d, J=8.5 114.7
9 7.07 dd, J=1.0, 8.0 123.0
1-OMe  3.80 s  51.6
6-OMe 3.93 s  55.9
7-OH 5.90 s
3.2. Effect of MF on cell viability 
   To evaluate the anti-inflammatory activity of MF, we 
examined the cytotoxic effects of MF and a dexamethasone 
(Dex) control on BMDMs. BMDMs were treated with MF (25 µg/
mL) or Dex (100 nmol/L) for various times, and the percentage 
of surviving cells was counted using CCK-8 cell viability 
assay. As shown in Figure 2, no significant difference 
was observed for MF or Dex-induced cell viability at the 
indicated times, up to 48 h (P>0.05). 
Figure 2. No effect on cell viability after treatment of BMDMs with MF or Dex. 
BMDMs were seeded in Corning Costar 48 well plate at a density of 1伊106 cells/
well. After 3-4 d, cells were treated with MF (25 µg/mL) for the times indicated. 
Cell viability was assessed after incubation for indicated times in the 
presence of CCK-8. Data are presented as the mean依SD of three independent 
experiments. 
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3.3. Inhibition of MF against cytokine production by LPS 
activated macrophages   
   Anti-inflammatory properties of MF concentrations 0, 5, 
10, and 25 µg/mL were confirmed by examination of their 
effect on pro-inflammatory cytokine production of IL-6, 
IFNγ, TNFα, and post-anti-inflammatory cytokine IL-10. 
The results (Figure 3) indicated that the release of IL6, INFγ, 
and TNFα was strongly inhibited in BMDMs while IL10 was 
unaffected compared to untreated control cells (P<0.05). 
These data indicate that MF could be a good candidate for 
use as an anti-inflammatory agent. At a concentration of 10 
µg/mL (45 µmol/L), release of all the tested cytokines in the 
treated BMDMs were suppressed by at least 50%. 
3.4. MF inhibits phosphorylation by p38 and JNK in MAPK 
pathway
   Mitogen activated protein kinases (MAPK) are a group 
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of signaling molecules that also appear to play important 
roles in inflammatory processes. At least three MAP kinase 
cascades are well described including, extracellular signal 
and regulated kinase, JNK and p38[8,9]. These have also been 
reported to differentially activate depending on the stimuli 
present and cell type affected[9]. As shown in Figure 4, the 
activation of p38 and JNK was significantly reduced in the 
MF-treated RAW 264.7 cells at a concentration of 25 µg/mL 
(compared to the control). 
Figure 3. Effect of MF on cytokines TNFα, IL6, IFNγ and IL10 produced by 
macrophages. 
BMDMs were treated with MF at concentrations of 0, 5, 10, and 25 µg/mL in 
vehicle DMSO 0.1% in 60 min before stimulation with LPS. Supernatants were 
harvested 18 h after stimulation with 1 µg/mL LPS to induce inflammation. 
Concentrations of IL-10, IFNγ, IL-6, and TNFα in the culture supernatants 
were determined by ELISA. Dexamethasone (Dex) was used as positive control. 
Data are presented as the mean依SD of three independent experiments.
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Figure 4. Inhibition of MF against p38 and JNK phosphorylation in BMDMs. 
BMDMs were treated with MF at concentrations of 25 µg/mL in vehicle 
DMSO 0.1% for 60 min before stimulation with LPS (1 µg/mL). The cells then 
were then analyzed with Western blot using p38, p-p38, JNK, and p-JNK 
antibodies.  
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3.5. Inhibition of MF against NO formation in BMDMs  
   Reactive oxygen species (ROS), such as H2O2, NO, 
superoxide anions, and hydroxyl radicals (OH) are often 
important intracellular signaling molecules in pathways 
involved in cell proliferation, stress responses and 
apoptosis[5,9]. The inhibitory effects of MF on activation of 
MAPK (phosphorylation of p38 and JNK), which was mentioned 
in section 3.4, suggested that p38 and JNK could be the 
important signals involved in the MF-induced inhibition 
of NO generation. Therefore, we investigated whether MF 
inhibits LPS-induced NO generation in BMDMs. The RAW264.7 
cells were treated with MF and inflammation was induced by 
using LPS. The data (Figure 5) indicated that LPS-induced NO 
generation was inhibited in a dose dependent manner with 
about 20% and 50% inhibition at concentrations 10 and 25 µg/
mL MF, respectively. 
3.6. Inhibition of MF against COX-2 expression
   COX-2 is primarily present at sites of inflammation 
and plays a role in the conversion of arachidonic acid 
to prostaglandin, resulting in pain and inflammation[10]. 
Inhibitors of COX-2 have profound anti-inflammatory 
effects[10]. We also examined COX-2 expression in MF-
treated and LPS-stimulated BMDMs, as COX-2 is an important 
inflammatory mediator that is induced by various stimuli, 
including LPS and cytokines[9]. As shown in Figure 6, MF 
clearly suppressed COX-2 expression at a concentration of 
25 µg/mL while the inhibitory effect seems to not be very 
profound at a concentration of 10 µg/mL. 
Figure 5. Inhibition of MF against NO generation in BMDMs. 
Raw 246.7 cells at density of 106 were seeded in Corning Costar 48 well plate 
for 16 h before treatment. The cells were treated with MF at concentrations of 
10 and 25 ug/mL for 60 min and activated with 1 ug/mL of LPS for another 1.5 
h. The culture supernatants were harvested by centrifuge and concentrations 
of NO were determined using a NO detection kit. Data are presented as the 
mean依SD of three independent experiments.   
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Figure 6. Inhibition of MF against COX-2 expression in BMDMs. 
RAW 246.7 cells were treated with MF at concentrations of 10 µg/mL (MF1) 
and 25 µg/mL (MF2) in vehicle DMSO 0.1% in Corning Costar 48 well plate for 
60 min before stimulation with LPS (1 µg/mL). The cells were then analyzed 
with Western blot using anti COX-2 antibody.   
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4. Discussion
   In the treatment of inflammation, non-steroid anti-
rheumatic drugs, such as acetylsalicylic acid, more 
commonly known as aspirin or ibuprofen, have been popular 
choices. However, many of these drugs cause potential 
risks and side effects, such as stomach and cardiovascular 
problems[11,12]. Therefore, novel anti-inflammatory, 
especially natural agents are badly needed. Plants are rich 
in naturally-occurring bioactive compounds. This is an ideal 
bio-resource to develop new therapeutic agents[13-15]. In an 
attempt to find novel anti-inflammatory agents from plants 
of Vietnam, we were screened and selected S. tuberosa, a 
traditional medicinal plant. We found the MF compound, 
and even though it is not a new compound, this is the first 
time that it has been isolated from this plant and shown to 
possess anti-inflammatory activity when tested in vitro.
   First, MF strongly inhibited MAPK phosphorylation induced 
by LPS, which affected two important signal pathways p38 
and JNK. The most well-known pathway involved in LPS-
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induced pro-inflammatory responses in macrophages 
is the MAPK pathway, which is involved intracellular 
signaling cascades[8,16]. Intense efforts have been made to 
develop and evaluate compounds that target components 
of these pathways[9,16]. The most extensive activity in 
MAPK inhibitor development has found with pJNK and p38, 
which regulate the production of TNFα and IL1[17]. p38 
inhibitors are expected to inhibit not only the production 
of pro-inflammatory cytokines, but also their actions, 
thereby interrupting the vicious cycle that often occurs in 
inflammatory and immune-responsive diseases[5,9]. Our data 
suggest that MF is a potential inhibitor of the MAPK pathway.
   Second, several studies have demonstrated that activation 
of MAPK plays a role in the regulation of inflammation by 
affecting the activation of NF-κB[8,17]. Moreover, NF-κB plays 
an important role in the regulation of inflammatory genes, 
such as, inducible nitric oxide synthetase (iNOS), COX-2, 
and TNF-α[9,10,17]. In our study, NF-κB expression was also 
evaluated in BMDMs using specific antibodies to the p50/105 
subunit of NF-κB. We found an only minor suppression of 
NF-κB expression by MF in the Western blot image at a 
concentration of 25 µg/mL (data not shown). However, the 
inhibitory effect of MF on NO generation and COX-2 at the 
same concentration suggests that MF could still be affecting 
the NF-κB pathway. Islam et al. demonstrated that anti-
inflammatory activity of ethyl ferulate, another derivative of 
ferulate acid comes from the inhibition of ROS production 
and the significant suppression of the NF-κB activity when 
the translocation of NF-κB p65 in LPS-stimulated RAW 
264.7 macrophages was measured[18].This suggests that an 
additional study would be warranted to further investigate 
this, perhaps by employing the use of an NF-κB reporter. 
Thus, it is possible that there could be cross-talk between 
the MAPK and the NF-κB signals that may be important for 
relaying the biological effect of MF. Moreover, Minutoli et 
al. demonstrated that during the development of testicular 
ischemia-reperfusion injury, the JNK and p38 signals were 
abolished when NF-κB was disrupted[19]. Sethi et al. also 
found that TNF-induced NF-κB activation was stopped in 
cells deleted of the MKK4 gene encoding activates both JNK 
and p38 MAPK[20]. 
   In summary, the present study suggests MF is a potential 
inflammatory compound isolated for the first time from 
medicinal plant S. tuberosa grown in Vietnam.  
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